06.07.2021
CGMP/Finished Pharmaceuticals/Adulterated
06.07.2021
CMO Selkirk blueprints $90M factory to help bring injectable drug manufacturing stateside fkansteiner Mon, 06/07/2021 - 09:53
06.07.2021
Merck investigating noose at NC vaccine plant as execs pledge swift response kdunleavy Mon, 06/07/2021 - 10:12
06.07.2021
FDA has approved Ultomiris (ravulizumab-cwvz) injection to treat patients aged one month and older with paroxysmal nocturnal hemoglobinuria (PNH), a rare, life-threatening blood disease.
06.07.2021
FDA approved Aduhelm (aducanumab) for the treatment of Alzheimer’s, a debilitating disease affecting 6.2 million Americans, using the Accelerated Approval pathway
06.07.2021
Roche, Pfizer and Novartis earn top marks from cancer patient groups during pandemic: survey bbulik Mon, 06/07/2021 - 11:14
06.07.2021
The FDA approved a drug for the treatment of Alzheimer’s under the accelerated approval pathway, which can be used for a drug for a serious or life-threatening illness that provides meaningful therapeutic advantage over existing treatments.
06.07.2021
ASCO: AstraZeneca details Calquence's heart safety edge over Imbruvica as both brace for BeiGene's rival Brukinsa aliu Mon, 06/07/2021 - 11:40
06.07.2021
This page contains the PCAC roster, which lists the current members and the current number of vacancies for the committee.
06.07.2021
Biogen's shockingly broad Aduhelm label—and $56K price—set up a $10B launch, analysts say nhigginsdunn Mon, 06/07/2021 - 14:08